Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
Vericel announces FDA approval of NexoBrid for pediatric severe thermal burns, offering a non-surgical eschar removal solution.
Highlighted Terms
Related News
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
Vericel announces FDA approval of NexoBrid for pediatric severe thermal burns, offering a non-surgical eschar removal solution.